Furthermore, several studies using AHR-silencing technology and various AHR ligands have demonstrated the preponderant role of AHR in the development of IL-22-producing T cells in several diseases, including AD [152,153], which, in turn, sustains abnormal epidermal barrier function [154]. The gene discussed is IL22; the disease is Alzheimer disease.